Cargando…
Heterologous expression of MlcE in Saccharomyces cerevisiae provides resistance to natural and semi-synthetic statins
Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the key enzyme in cholesterol biosynthesis. Their extensive use in treatment and prevention of cardiovascular diseases placed statins among the best selling drugs. Construction of Saccharomyces cerevisiae cell factory for the...
Autores principales: | Ley, Ana, Coumou, Hilde Cornelijne, Frandsen, Rasmus John Normand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193252/ https://www.ncbi.nlm.nih.gov/pubmed/34150514 http://dx.doi.org/10.1016/j.meteno.2015.09.003 |
Ejemplares similares
-
Synthetic Promoters and Transcription Factors for Heterologous Protein Expression in Saccharomyces cerevisiae
por: Machens, Fabian, et al.
Publicado: (2017) -
Synthetic propeptide design to enhance the secretion of heterologous proteins by Saccharomyces cerevisiae
por: Cho, Ji Sung, et al.
Publicado: (2022) -
Heterologous production of levopimaric acid in Saccharomyces cerevisiae
por: Liu, Ting, et al.
Publicado: (2018) -
Heterologous biosynthesis and manipulation of crocetin in Saccharomyces cerevisiae
por: Chai, Fenghua, et al.
Publicado: (2017) -
Comparison of heterologous xylose transporters in recombinant Saccharomyces cerevisiae
por: Runquist, David, et al.
Publicado: (2010)